Gnh India Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 10.16 Cr
as on 15-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 43.81%
(FY 2023)
- Profit 38.51%
(FY 2023)
- Ebitda -23.89%
(FY 2023)
- Net Worth 46.31%
(FY 2023)
- Total Assets 74.38%
(FY 2023)
About Gnh India Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 10.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gnh India Pharmaceuticals Limited India are Aditya Prajapati as CFO and Tanzeelah Shaikh as Company Secretary. Jessica Gupta, Piyush Gupta, Vinesh Mestry, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909MH2018PLC309277
- Company No.
309277
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 May 2018
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Gnh India Pharmaceuticals Limited offer?
Gnh India Pharmaceuticals Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines.
Who are the key members and board of directors at Gnh India Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Gupta  | Managing Director | 11-May-2018 | Current |
| Aditya Prajapati | CFO | 03-Sep-2024 | Current |
| Tanzeelah Shaikh | Company Secretary | 03-Sep-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jessica Gupta | Whole-Time Director | 11-May-2018 | Current |
| Vinesh Mestry | Director | Current | |
| Harshal Parmar | Director | 28-Aug-2024 | Current |
| Savithav Nair | Director | 28-Aug-2024 | Current |
Financial Performance of Gnh India Pharmaceuticals.
Gnh India Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.81% increase. The company also saw a substantial improvement in profitability, with a 38.51% increase in profit. The company's net worth Soared by an impressive increase of 46.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gnh India Pharmaceuticals?
In 2023, Gnh India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ricoh Thermal Media Asia Pacific Private LimitedActive 13 years 2 daysVinesh Mestry is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gnh India Pharmaceuticals?
Unlock and access historical data on people associated with Gnh India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gnh India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gnh India Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
